Xencor (XNCR)

Xencor (XNCR) – FDA

Feb 6, 2023 08:05 AM Atreca (BCEL) and Xencor (XNCR) to Develop T Cell Engaging Bispecific Antibody Directed Against Novel Solid Tumor Target
Dec 12, 2022 10:04 AM Xencor (XNCR) Presents Data from Phase 1 Study of Plamotamab in Relapsed or Refractory Non-Hodgkin Lymphoma at the American Society of Hematology Annual Meeting
Nov 10, 2022 09:01 AM
Nov 7, 2022 04:02 PM
May 26, 2022 05:06 PM
Dec 13, 2021 05:11 AM
Nov 22, 2021 05:42 AM
Nov 12, 2021 07:09 AM
Nov 8, 2021 04:51 PM
Nov 3, 2021 09:03 AM
Apr 28, 2021 05:32 PM
Dec 29, 2020 07:42 AM
Nov 11, 2020 04:04 PM
Nov 9, 2020 08:08 AM
Oct 2, 2020 09:04 AM
Jul 8, 2020 08:03 AM
Jun 22, 2020 09:14 AM
Dec 9, 2019 10:03 AM
Jun 3, 2019 08:05 AM
Apr 30, 2019 08:12 AM
Feb 20, 2019 07:09 AM
Dec 3, 2018 05:45 PM
Oct 5, 2018 08:05 AM
Jul 12, 2018 04:00 PM
Apr 18, 2018 09:02 AM
Feb 22, 2018 08:10 AM
Dec 5, 2017 08:05 AM
Oct 20, 2017 04:01 PM
Jun 16, 2017 08:01 AM
May 11, 2017 08:09 AM
Nov 13, 2016 09:11 AM
Nov 11, 2016 07:07 AM
Sep 15, 2016 08:06 AM
Jun 28, 2016 11:17 AM
Jun 28, 2016 10:10 AM
Mar 7, 2016 04:02 PM
Nov 4, 2015 07:46 AM
Sep 24, 2015 08:18 AM
Sep 16, 2015 07:32 AM
Aug 5, 2015 08:41 AM
May 14, 2015 08:57 AM
Jan 30, 2015 07:51 AM
Jan 29, 2015 07:17 AM
Jan 29, 2015 07:16 AM
Apr 10, 2014 08:06 AM